Goldman Sachs’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Goldman Sachs's OGN Position: Q1 2026 in Review
Goldman Sachs reduced its Organon & Co (OGN) stake by 15% in Q1 2026, selling an estimated $2.07M and leaving 1,605,325 shares worth $9.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3105.
Goldman Sachs first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $45.6M in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Goldman Sachs held 1,605,325 shares of Organon & Co worth $9.62M as of Q1 2026.
- Goldman Sachs sold 275,290 Organon & Co shares in Q1 2026, an estimated $2.07M.
- Organon & Co made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3105 holding.
- Goldman Sachs first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Goldman Sachs's Organon & Co position peaked at $45.6M in Q2 2023.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.